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Editorial
Training and Consistency in Stroke Assessments
Kennedy R. Lees, MD, FRCP
See related article, pages 2507–2511 and 2557–2559.
Stroke is a global disease. It needs global tools for descriptionand outcome assessment, common definitions for risk fac-
tors, common definitions for complications such as symptomatic
hemorrhage, and common investigation protocols.
Research into treatments for stroke depends on enrollment
of large numbers of patients, possible only through interna-
tional cooperation. Wide variation in initial stroke severity
requires us to describe the population that we enroll. The
National Institutes of Health Stroke Scale is now the most
widely used scale for measuring stroke severity in clinical
trials1 and lies second only to the modified Rankin Scale for
choice as a primary end point.2 This trend to homogeneity is
important; consistency in language is required within trials
and to interpret their results. For example, use of common
scales allowed pooling of data from the National Institute of
Neurological Diseases and Stroke, Alteplase Thrombolysis
for Acute Noninterventional Therapy in Ischemic Stroke, and
European Cooperative Acute Stroke Study trials to examine
the influence of onset to treatment time with alteplase.3 It
assists selection of patients for routine care through transla-
tion of trial results into practice. It lets us understand trends in
clinical practice, facilitating comparisons over time and
across regions.4 With clinical trial data from 10s of thousands
of patients archived by groups such as the Virtual Interna-
tional Stroke Trials Archive,5 it is now possible to examine
trends in natural history, to plan selection criteria for future
trials, and perhaps to crossvalidate trial results using data that
were collected in a consistent manner using common tools.
These benefits that accrue from use of common scales
depend on consistency of application across raters and over
time. There will be a temptation to modify the scale to
improve reliability, by adding or omitting items, and by
adjusting the weighting given to components. This should be
resisted. An imperfect scale applied consistently will be more
useful than modifications intended to improve validity or
reliability. The articles by Lyden and colleagues in this
journal6,7 provide reassurance in this respect. By demonstrat-
ing that even among general (nonexpert) users, the National
Institutes of Health Stroke Scale can achieve good interrater
reliability, Lyden at al have given further support to the
choice of National Institutes of Health Stroke Scale as the
pre-eminent stroke severity rating. Pezzella and colleagues7
have found that with translation into Italian, the scale can
achieve similar reliability as the English version. The lower
reliability of the scale in their hands among nurses contrasts
with the more extensive analysis of the English version by
Lyden.6 He and colleagues find that nonneurologists are just
as reliable in their application of the scoring rules. Training
can be robustly applied across multiple venues and special-
ties. This pattern appears to be consistent with other scales
such as modified Rankin Scale.8 Of course, language forms
only a component of National Institutes of Health Stroke
Scale both with regard to scoring and instructions; mostly the
scoring is based on observation of physical performance.
Validity of the National Institutes of Health Stroke Scale in
other languages thus does not guarantee that interview-based
assessments such as the modified Rankin Scale will achieve
similar consistency after translation.
It would be intriguing to re-examine trials to assess the
extent to which the expertise or reliability of the individual
rater contributes to the variation in severity ratings, to
outcome assessments, and perhaps even to the trial conclu-
sion. This must be a topic for continued effort because
description of patients’ baseline characteristics and outcomes
plays such a crucial role in determining whom we should treat
and how effective are our interventions.
We should congratulate Dr Lyden and colleagues for
taking an imperfect tool and guiding its use in a way that has
made it an invaluable part of every modern stroke trial and a
mandatory skill for professionals in at least one country.
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